Remodulin
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.remodulinpro.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Remodulin
Remodulin is a parenteral treprostinil therapy designed to treat pulmonary arterial hypertension (PAH) by delivering medication via subcutaneous and intravenous methods. The company offers various innovative pump systems and provides extensive support and resources for healthcare professionals and patients alike. Their focus is on improving patient care and treatment outcomes through effective dosing, titration, and assistance programs. With over 20 years of experience, Remodulin aims to enhance the treatment experience for patients managing PAH.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Remodulin your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Remodulin launches new products
Check if Remodulin has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Remodulin has new funding data
Click to see if Remodulin had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Remodulin
Remodulin, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Remodulin is spiking on competitors!
Earning: See what the market has to say on Remodulin recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Remodulin
Compare insights from companies similar to Remodulin, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Remodulin
<$5M
11-50
Private
-
2002
N/A
Company Profile Activity
Activity Insights
Remodulin is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Remodulin is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Remodulin.
Remodulin Tech Stack
A closer look at the technologies used by Remodulin
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Remodulin
Sign Up For FreeTo access detailed company insights
Remodulin is a parenteral treprostinil therapy designed to treat pulmonary arterial hypertension (PAH) by delivering medication via subcutaneous and intravenous methods. The company offers various innovative pump systems and provides extensive support and resources for healthcare professionals and patients alike. Their focus is on improving patient... Read More
